Phase 1 Trial of Vamorolone, a First-in-Class Steroid, Shows Improvements in Side Effects via Biomarkers Bridged to Clinical Outcomes.

Eric P Hoffman
Valerie Riddle
Maxime A Siegler
Daniel Dickerson
Miroslav Backonja
William G Kramer
Kanneboyina Nagaraju
Heather Gordish-Dressman, George Washington University
Jesse M Damsker
John M McCall

Abstract